UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
UK Approves Arthritis Drugs for Critically Ill COVID-19 Patients
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.
The immunosuppressive drugs tocilizumab and sarilumab improved survival and recovery time of intensive care COVID-19 patients, according to a preprint.